Conferences
#ESHBMFS2024

ESH-EBMT-EHA-IPIG 3rd Translational Research Conference
Bone Marrow Failure and Leukaemia Predisposition Syndromes

‍

#ESHBMFS2024
Translational
November 15-17, 2024
-
Paris, France

Chairs: Carmem Bonfim, Tim Brümmendorf, Antonio Risitano, Sharon Savage

Scientific Committee: Beatrice Drexler, Carlo Dufour, Morag Griffin, Régis Peffault de Latour

ESH-EBMT-EHA-IPIG 3rd Translational Research Conference
Bone Marrow Failure and Leukaemia Predisposition Syndromes

‍

Information

‍

ABOUT THE CONFERENCE:

The ESH-EBMT-EHA-IPIG 3rd Translational Research Conference: Bone Marrow Failure and Leukaemia Predisposition Syndromes will be of particular value for clinicians and non- clinical scientists, M.D. and Ph.D. of all ages interested in the biology, pathophysiology, diagnosis and treatment of bone marrow failure syndromes (BMFS) and leukaemia predisposition syndromes. We will not only discuss the standard of care in acquired but also inherited BMFS occurring in adult and paediatric patients, but particularly focus on new underlying principles and evolving new treatment strategies.In good tradition of ESH, we will put special effort on low threshold exchange between young scientists and experts in the field, as well as between clinicians and basic scientists. Meet-the-experts workshop as well as poster walks will allow to highlight topics of special attention and to enable further in-depth exchange. Our dedicated faculty will secure the highest standard of both clinical, translational and basic research.

‍

SCIENTIFIC TOPICS:

• Stem cell biology
• Inherited predisposition to leukaemia
• Constitutional marrow failure 2
• Constitutional marrow failure 3: telomere biology diseases and others…
• AA & PNH: 1. Pathophysiology and diagnosis
• AA & PNH: 2. CHIP and clonal evolution in BMFS
• Treatment of aplastic anaemia
• Treatment of paroxysmal nocturnal haemoglobinuria
• Expanding areas in BMFS

‍

Programme

Read the final programme!

CLICK HERE
ON-DEMAND CONTENT AVAILABLE
CLICK HERE

Corporate partners

With the support of*:
‍

‍

Major Conference Partners
*******

‍

‍

‍Level 1 Conference Partner
*******

‍

‍

Supporting Conference Partner
*******


‍*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.

‍

Advancing haematology through international leading-edge disease- focused conferences.

Explore a portfolio of leading-edge scientific, translational research and clinically oriented meetings, designed to foster scientific exchange, practical insight, education and collaboration across clinical and research fields.
Explore all conferences